Spots Global Cancer Trial Database for 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Official Title:
Study ID: NCT01373736
Interventions
Study Description
Brief Summary: The study is designed to study the safety and effectiveness of 123I-MIBG as a diagnostic imaging agent in evaluating patients with known or suspected neuroendocrine tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Vancouver Coastal Health, Vancouver, British Columbia, Canada
Contact Details
Name: Daniel Worsley, MD
Affiliation: Vancouver Coastal Health
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
